Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Skinvisible (SKVI) EPS (Weighted Average and Diluted) (2018 - 2024)

Skinvisible's EPS (Weighted Average and Diluted) history spans 7 years, with the latest figure at $0.08 for Q4 2024.

  • For Q4 2024, EPS (Weighted Average and Diluted) rose 233.33% year-over-year to $0.08; the TTM value through Dec 2024 reached -$0.11, up 78.85%, while the annual FY2024 figure was -$0.11, 78.85% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2024 was $0.08 at Skinvisible, up from -$0.06 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.08 in Q4 2024 and bottomed at -$0.33 in Q1 2023.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.06 (2021), against an average of -$0.07.
  • The largest annual shift saw EPS (Weighted Average and Diluted) tumbled 560.0% in 2023 before it skyrocketed 233.33% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.07 in 2020, then skyrocketed by 39.08% to -$0.04 in 2021, then tumbled by 125.0% to -$0.09 in 2022, then surged by 33.33% to -$0.06 in 2023, then surged by 233.33% to $0.08 in 2024.
  • Per Business Quant, the three most recent readings for SKVI's EPS (Weighted Average and Diluted) are $0.08 (Q4 2024), -$0.06 (Q3 2024), and -$0.07 (Q2 2024).